Baldini G M
Società Italiana di Medicina Transfusionale eol Immunoematologia (SIMTI).
Hematol Cell Ther. 1996 May;38 Suppl 1:S9-18.
In Italy, under current legislation, blood collection and productive plasmapheresis are managed by the National Health Service, either directly or indirectly. Donation is voluntary and unpaid. The promotion of donation is addressed to the whole of the population and the organization of periodical donors in associations is encouraged. Donor selection aims at guaranteeing the utmost security of both donors and recipients. Selection procedures are specified by law. Private industries fractionate the source plasma into derivatives. The National Blood and Plasma Plan has an objective to reach an availability of 2,280,000 units of whole blood (i.e. 40 units/1,000 inhabitants) and of 800,000 1 of plasma/annum. At present, whole blood collection covers over 80% of national needs, while plasma production satisfies over 60% of national needs. Self sufficiency in blood and plasma has not so far been achieved. In 1994 the amount of apheresis plasma covers 30% of the amount necessary to achieve self sufficiency. In Italy the technology for plasma collection by apheresis is already adequate in order to reach the above-mentioned objective. On the other hand, in order to reach self-sufficiency, the number of donors undergoing apheresis procedures seems completely insufficient, thus indicating that the priority objective should be the recruitment of new plasma donors.
在意大利，根据现行法律，采血和单采血浆由国家卫生服务机构直接或间接管理。献血是自愿且无偿的。面向全体民众开展献血宣传，并鼓励组织定期献血者协会。献血者筛选旨在确保献血者和受血者的最大安全。筛选程序由法律规定。私营企业将原料血浆分离成各种衍生物。国家血液和血浆计划的目标是实现全血供应量达到228万单位（即每1000名居民40单位），以及每年血浆供应量达到80万升。目前，全血采集量满足了国家需求的80%以上，而血浆产量满足了国家需求的60%以上。血液和血浆尚未实现自给自足。1994年，单采血浆量占实现自给自足所需量的30%。在意大利，单采血浆技术已经足以实现上述目标。另一方面，为实现自给自足，接受单采程序的献血者数量似乎完全不足，因此表明首要目标应该是招募新的血浆献血者。
